Tech Moves: Eliem CEO out amid layoffs; Rokt taps Amazon vet to lead new Seattle office; and more — Bob Azelby is leaving his position as president and CEO of Elieum Therapeutics and stepping down from its board.… Read More
Biotech companies fuel IPO boom in Washington state over the past year In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped… Read More
Podcast Wall Street goes to pot, and to the dogs — and that’s a good thing for Seattle’s startup scene An online marketplace that helps to facilitate trade between marijuana sellers and buyers will soon see its own stock traded… Read More
Eliem is latest Seattle-area biotech to go public, raises $80M to help fuel treatments for nervous system disorders Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares at $12.50 and raising… Read More
Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public Eliem Therapeutics, a clinical stage biotech company generating therapies for pain, depression and other nervous-system related conditions, has filed to… Read More
Led by former Juno and Alder exec, Seattle neurology startup Eliem Therapeutics raises $80M New funding: Eliem Therapeutics, a new Seattle biotech startup led by former Juno Therapeutics exec Bob Azelby, raised $80 million… Read More
